In Vivo Formation of Adrenal Organoids in a Novel Porcine Model of Adrenocortical Cell Transplantation

• Published in: Endocrinology (Philadelphia) Vol. 165; no. 8
• Main Authors: Clarke, Brigette Marie, Kireta, Svjetlana, Johnston, Julie, Christou, Chris, Greenwood, John Edward, Hurtado, Plinio R, Manavis, Jim, Coates, Patrick Toby, Torpy, David J
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 01.07.2024
• Subjects: Addison's disease; Adrenal Cortex - cytology; Adrenal Cortex - metabolism; Adrenal Glands - metabolism; Adrenalectomy; Adrenocorticotropic hormone; Animal models; Animals; Biodegradability; Biodegradation; Cell culture; Cell proliferation; Cell Transplantation - methods; Cellular manufacture; Corticoids; Corticosteroids; Female; Histochemistry; Hydrocortisone; Hydrocortisone - blood; In vivo methods and tests; Islet cells; Models, Animal; Organoids; Pancreas transplantation; Pancreatic islet transplantation; Steroids; Swine; Transplantation; Transplants & implants; adrenal; corticosteroids; animal model; Addison's disease; transplantation
• DOI: 10.1210/endocr/bqae086
• ISSN: 1945-7170; 0013-7227

Abstract Recognizing the limitations of current therapies for Addison's disease, novel treatments that replicate dynamic physiologic corticosteroid secretion, under control of ACTH, are required. The aim of these experiments was to evaluate the feasibility of adrenocortical cell transplantation (ACT) in a large animal model, adapting methods successfully used for intracutaneous pancreatic islet cell transplantation, using a fully biodegradable temporizing matrix. Autologous porcine ACT was undertaken by bilateral adrenalectomy, cell isolation, culture, and intracutaneous injection into a skin site preprepared using a biodegradable temporizing matrix (BTM) foam. Hydrocortisone support was provided during adrenocortical cell engraftment and weaned as tolerated. Blood adrenocortical hormone concentrations were monitored, and the transplant site was examined at endpoint. Outcome measures included cellular histochemistry, systemic hormone production, and hydrocortisone independence. Transplanted adrenocortical cells showed a capability to survive and proliferate within the intracutaneous site and an ability to self-organize into discrete tissue organoids with features of the normal adrenal histologic architecture. Interpretation of systemic hormone levels was confounded by the identification of accessory adrenals and regenerative cortical tissue within the adrenal bed postmortem. Corticosteroids were unable to be completely ceased. ACT in a large animal model has not previously been attempted, yet it is an important step toward clinical translation. These results demonstrate rhe potential for ACT based on the development of adrenal organoids at the BTM site. However, the inability to achieve clinically relevant systemic hormone production suggests insufficient function, likely attributable to insufficient cells through delivered dose and subsequent proliferation.